GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,926,000 | +952.6% | 189,723 | +435.5% | 0.02% | +2000.0% |
| Q1 2022 | $1,228,000 | -60.9% | 35,431 | -66.9% | 0.00% | -66.7% |
| Q4 2021 | $3,143,000 | +20.5% | 107,066 | +5.5% | 0.00% | 0.0% |
| Q3 2021 | $2,608,000 | +10.8% | 101,473 | +51.3% | 0.00% | 0.0% |
| Q2 2021 | $2,354,000 | +41.6% | 67,063 | +65.5% | 0.00% | +50.0% |
| Q1 2021 | $1,662,000 | -30.0% | 40,520 | -26.1% | 0.00% | -33.3% |
| Q4 2020 | $2,373,000 | +119.9% | 54,801 | +180.2% | 0.00% | +50.0% |
| Q3 2020 | $1,079,000 | +143.0% | 19,556 | +178.0% | 0.00% | +100.0% |
| Q2 2020 | $444,000 | -85.2% | 7,034 | -88.2% | 0.00% | -85.7% |
| Q1 2020 | $3,005,000 | +531.3% | 59,823 | +902.7% | 0.01% | +600.0% |
| Q4 2019 | $476,000 | +67.0% | 5,966 | +1.5% | 0.00% | 0.0% |
| Q3 2019 | $285,000 | – | 5,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |